BioRestorative Therapies amends articles of incorporation
BioRestorative Therapies filed a certificate of amendment to its articles of incorporation with the SEC. The filing indicates a corporate governance or structural modification but …
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
BioRestorative Therapies filed a certificate of amendment to its articles of incorporation with the SEC. The filing indicates a corporate governance or structural modification but …
Skye Bioscience filed a Certificate of Amendment to its Articles of Incorporation with Nevada, with shareholder approval of 58.63%, effective May 28, 2026. The amendment modifies t…
DigitalBridge Group amended its 2024 Omnibus Stock Incentive Plan to increase the share reserve by 6 million shares, bringing total authorization to 11.5 million shares. The amendm…
Gulf Resources Inc. received a delinquency notification from NASDAQ on May 26, 2026 for failing to timely file its Form 10-Q for Q1 2026, adding to an earlier notice regarding a la…
PricewaterhouseCoopers LLP confirmed it agrees with statements made by Oxford Square Capital Corp regarding an auditor-related matter filed under Item 4.01 of Form 8-K. The filing …
Entravision Communications amended and restated its 2004 Equity Incentive Plan, subject to stockholder approval at the May 28, 2026 annual meeting. The plan provides equity awards …
First Interstate BancSystem amended its certificate of incorporation to implement majority voting for director elections, effective immediately. The change eliminates cumulative vo…
Aperture AC filed audited financial statements showing a balance sheet as of May 22, 2026. The auditor noted substantial doubt about going concern due to mandatory liquidation time…
Faraday Future Intelligent Electric Inc. filed its tenth certificate of amendment to its Third Amended and Restated Certificate of Incorporation with Delaware. The filing documents…
Silgan Holdings amended its 2004 Stock Incentive Plan to increase authorized shares by 4 million and raise individual grant limits, effective April 2, 2026 subject to 2026 annual m…
The fund's adviser agreed to waive half of the income-based incentive fee for April 2026 under a new agreement executed May 28, 2026. The partial waiver reduces near-term costs for…
The FDA released draft guidance aimed at cutting unnecessary animal testing in nonclinical safety assessments for certain cancer medications. The initiative seeks to streamline dru…
Replimune announced it will resubmit its Biologics License Application for RP1 in combination with nivolumab for advanced melanoma following productive FDA discussions, with the ag…
Moleculin presented pooled analysis of 90 patients showing no detectable cardiotoxicity with Annamycin despite cumulative exposure levels far exceeding conventional anthracycline l…
Vyome Holdings signed an agreement with Impetis Biosciences to in-license two JAK inhibitor assets targeting a $57B market and submitted an FDA Orphan Drug Designation application …
Classover Holdings, Inc. submitted an EX-3.1 exhibit documenting a certificate of change. The filing indicates a corporate structural modification requiring SEC disclosure.
Caleres Inc has filed amended bylaws establishing procedures for stockholder meetings and director nominations. The update clarifies governance rules for annual meetings and stockh…
Sturm Ruger & Co amended its certificate of incorporation to increase authorized common stock to 60 million shares and authorize 50,000 shares of non-voting common stock. The amend…
Relmada Therapeutics, Inc. filed an amended and restated certificate of incorporation with Nevada Secretary of State on May 28, 2026, with stockholder approval of 62.04% voting in …
Richtech Robotics Inc. received a notice from Nasdaq that it failed to timely file its Form 10-Q for Q1 2026, violating Listing Rule 5250(c)(1). The company has until July 21, 2026…